Maximilian Pistor

St. Josef Hospital
Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Higher disease reactivation risk in women after fingolimod withdrawal.

Higher disease reactivation risk in women after fingolimod withdrawal.

Journal: Acta neuropathologica communications

Published: March 17, 2026

Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis.

Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis.

Journal: Human brain mapping

Published: June 03, 2022

Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS).

Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS).

Journal: Multiple sclerosis and related disorders

Published: April 11, 2022

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.

Journal: Therapeutic advances in neurological disorders

Published: March 04, 2022

Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort.

Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort.

Journal: CNS neuroscience & therapeutics

Published: November 30, 2021

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.

Journal: Annals of the rheumatic diseases

Published: April 29, 2021

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.

Journal: Cells

Published: September 03, 2020

Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.

Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 25, 2020

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis.

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis.

Journal: Journal of neuroinflammation

Published: June 14, 2019

Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.

Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.

Journal: Acta neuropathologica

Published: December 07, 2018

Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient Department.

Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient Department.

Journal: Pharmacopsychiatry

Published: February 02, 2018

1,25-OH2 vitamin D3 and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL).

1,25-OH2 vitamin D3 and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL).

Journal: Leukemia research reports

Published: July 10, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026